Epygenix Therapeutics Submits Investigational New Drug Application for EPX-100 to the U.S. FDA for the Treatment of Patients With Dravet Syndrome

Read Full Release Here:

https://www.prnewswire.com/news-releases/epygenix-therapeutics-submits-investigational-new-drug-application-for-epx-100-to-the-us-fda-for-the-treatment-of-patients-with-dravet-syndrome-300872863.html